MedPath

Diclofenamide

Generic Name
Diclofenamide
Brand Names
Keveyis
Drug Type
Small Molecule
Chemical Formula
C6H6Cl2N2O4S2
CAS Number
120-97-8
Unique Ingredient Identifier
VVJ6673MHY

Overview

A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.

Background

A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.

Indication

For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure

Associated Conditions

  • Hyperkalemic Periodic Paralysis
  • Hypokalemic Periodic Paralysis

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code
Keveyis
Strongbridge US Inc.
ORAL
50 mg in 1 1
2021/12/13
71090-001
Dichlorphenamide
ORAL
50 mg in 1 1
2023/01/05
13668-676
Dichlorphenamide
ORAL
50 mg in 1 1
2023/03/09
72065-002

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

Singapore Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.

No Singapore products found

No Singapore products found for this drug

China Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import
双氯非那胺片
国药准字H31020561
片剂
N/A
25mg
Chemical Drug
Approved
2020/08/19
Domestic

Australia Approved Products

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient

No Australia products found

No Australia products found for this drug

© Copyright 2025. All Rights Reserved by MedPath